Skip to search formSkip to main contentSkip to account menu

SB 222657

Known as: SB-222657 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
  • M. Booker
  • IDrugs : the investigational drugs journal
  • 2001
  • Corpus ID: 40339235
GlaxoSmithKline is investigating a series of substituted pyrimidin-4-ones, including SB-435495, as reversible inhibitors of… 
Highly Cited
1999
Highly Cited
1999
A novel and potent azetidinone inhibitor of the lipoprotein-associated phospholipase A2 (Lp-PLA2), i.e. platelet-activating…